Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-029571
Filing Date
2020-10-28
Accepted
2020-10-28 20:46:45
Documents
2
Period of Report
2020-10-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4209
2 EX-24 DOCUMENT attachment1.htm EX-24 4822
  Complete submission text file 0000899243-20-029571.txt   10434
Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 18 DESBROSSES ST. NEW YORK NY 10013
Business Address
Shapiro David (Reporting) CIK: 0001559570 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39655 | Film No.: 201270171

Mailing Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200
Business Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200 45-70-70-52-10
Galecto Inc. (Issuer) CIK: 0001800315 (see all company filings)

EIN.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations